COMPOSITION PHARMACEUTIQUE POUR INHIBER LA RÉPONSE IMMUNITAIRE PAR INDUCTION DE LA DIFFÉRENCIATION EN CELLULES T RÉGULATRICES ET PROMOUVOIR LA PROLIFÉRATION DES CELLULES T RÉGULATRICES
The present invention relates to new medical use of (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholine-4-yl)methyl-1H-indol-7-yl]amine, and more particularly, to a pharmaceutical composition containing the compound as an active ingredient, which is used for inhibiting an immune response, and/or for inducing differentiation into regulator T cells from undifferentiated T cells and/or promoting proliferation of regulator T cells.Cette invention concerne un nouvel usage médical de la (tétrahydropyran- 4-yl)-[2-phényl-5-(1,1-dioxo-thiomorpholine-4-yl)méthyl-1H-indol-7-yl]-amine, et plus particulièrement, une composition pharmaceutique contenant ce composé à titre de principe actif, qui est utilisé pour inhiber une réponse immunitaire, et/ou pour induire la différenciation en cellules T régulatrices de cellules T non différenciées et/ou promouvoir la prolifération des cellules T régulatrices.본 발명은 (테트라하이드로피란-4-일)-[2-페닐-5-(1,1-디옥소-티오몰포린-4-일)메틸-1H-인돌-7-일]아민의 새로운 의약용도에 관한 것으로, 상기 화합물을 활성 성분으로 함유하는 면역 반응 억제용 및/또는 미분화 T 세포로부터 조절 T 세포로의 분화 유도 및/또는 조절 T 세포의 증식 촉진용 약학 조성물에 관한 것이다.
